Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 12/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1238109 | 1.00 | CA1 (0.34) | CA1CA2CA4KMT2ACYP19A1 | |
| SCHEMBL15660011 | 0.75 | CRBN (0.35) | KMT2AMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL9959584 | 0.71 | CYP19A1 (0.36) | CYP19A1 | |
| SCHEMBL9960249 | 0.69 | CRBN (0.32) | — | |
| SCHEMBL11368267 | 0.68 | CA1 (0.37) | CA1CA2CA4KMT2ACYP19A1 | |
| SCHEMBL9959189 | 0.67 | MME (0.30) | — | |
| SCHEMBL5911624 | 0.67 | DDB1 (0.51) | KMT2ACYP19A1 | |
| SCHEMBL660844 | 0.67 | — | — | |
| SCHEMBL7751356 | 0.65 | CRBN (0.36) | KMT2ACYP19A1ESR2ESR1MEN1 | |
| SCHEMBL23645791 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0982406-B1 | Microbial production of actinol | DSM IP ASSETS BV (NL) | 2006-03-01 | — | — | EP | claimed |
| US-6444460-B1 | A PROCESS FOR MAKING (4R, 6R)-4-HYDROXY-2,2,6-TRIMETHYLCYCLOHEXANONE BY CONTACTING (6R)-2,2,6-TRIMETHYLCYCLOHEXANEDIONE WITH A MICROORGANISM WHICH IS SELECTED FROM MICROORGANISMS OF THE GENERA | ROCHE VITAMINS, INC. | 2002-09-03 | — | — | US | claimed |
| EP-0982406-A2 | Microbial production of actinol | F. HOFFMANN-LA ROCHE AG (CH) | 2000-03-01 | — | — | EP | claimed |
| CN-1246466-C | Microbe process for preparing (4R, 6R)-4-hydroxyl-2,2,6-trimethyl cyclohexanone | DSM IP ASSET N V (NL) | 2006-03-22 | — | — | CN | disclosed |
| EP-0982406-B1 | Microbial production of actinol | DSM IP ASSETS BV (NL) | 2006-03-01 | — | — | EP | disclosed |
| US-6444460-B1 | A PROCESS FOR MAKING (4R, 6R)-4-HYDROXY-2,2,6-TRIMETHYLCYCLOHEXANONE BY CONTACTING (6R)-2,2,6-TRIMETHYLCYCLOHEXANEDIONE WITH A MICROORGANISM WHICH IS SELECTED FROM MICROORGANISMS OF THE GENERA | ROCHE VITAMINS, INC. | 2002-09-03 | — | — | US | disclosed |
| US-6444460-B1 | A PROCESS FOR MAKING (4R, 6R)-4-HYDROXY-2,2,6-TRIMETHYLCYCLOHEXANONE BY CONTACTING (6R)-2,2,6-TRIMETHYLCYCLOHEXANEDIONE WITH A MICROORGANISM WHICH IS SELECTED FROM MICROORGANISMS OF THE GENERA | ROCHE VITAMINS, INC. | 2002-09-03 | — | — | US | disclosed |
| EP-0982406-A3 | Microbial production of actinol | F. HOFFMANN-LA ROCHE AG (CH) | 2000-09-20 | — | — | EP | disclosed |
| CN-1254760-A | Microbe process for preparing (4R, 6R)-4-hydroxyl-2,2,6-trimethyl cyclohexanone | HOFFMANN LA ROCHE (CH) | 2000-05-31 | — | — | CN | disclosed |
| JP-2000069986-A | PRODUCTION OF ACTINOL BY MICROORGANISM | F HOFFMANN LA ROCHE AG | 2000-03-07 | — | — | JP | disclosed |
| EP-0982406-A2 | Microbial production of actinol | F. HOFFMANN-LA ROCHE AG (CH) | 2000-03-01 | — | — | EP | disclosed |
| EP-0982406-A2 | Microbial production of actinol | F. HOFFMANN-LA ROCHE AG (CH) | 2000-03-01 | — | — | EP | disclosed |